Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.4636
-0.0483 (-9.44%)
At close: Jun 27, 2025, 4:00 PM
0.4700
+0.0064 (1.38%)
After-hours: Jun 27, 2025, 7:51 PM EDT
Harvard Bioscience Stock Forecast
HBIO's stock price has decreased by -83.96% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Harvard Bioscience stock have an average target of 3, which predicts a 547.11% increase from the current stock price of 0.46.
Price Target: $3 (+547.11%)
Analyst Consensus: Buy
* Price targets were last updated on May 13, 2025.
Analyst Ratings
The average analyst rating for Harvard Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $4.5 → $3 | Buy | Maintains | $4.5 → $3 | +547.11% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $5.5 → $4.5 | Buy | Maintains | $5.5 → $4.5 | +870.66% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,409.92% | Jun 22, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +1,409.92% | Apr 26, 2023 |
Financial Forecast
Revenue This Year
88.89M
from 94.14M
Decreased by -5.57%
Revenue Next Year
97.56M
from 88.89M
Increased by 9.75%
EPS This Year
0.05
from -0.28
EPS Next Year
0.09
from 0.05
Increased by 70.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 91.7M | 100.6M |
| Avg | 88.9M | 97.6M |
| Low | 85.3M | 93.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | -2.6% | 13.2% |
| Avg | -5.6% | 9.8% |
| Low | -9.4% | 5.3% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.08 | 0.14 |
| Avg | 0.05 | 0.09 |
| Low | 0.02 | 0.04 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 167.6% |
| Avg | - | 70.0% |
| Low | - | -23.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.